Search Results - "Gabazza, E.C."

Refine Results
  1. 1

    What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse? by MORSER, J., GABAZZA, E. C., MYLES, T., LEUNG, L. L. K.

    Published in Journal of thrombosis and haemostasis (01-05-2010)
    “…Thrombin‐activatable fibrinolysis inhibitor (TAFI) is a circulating zymogen that is activated physiologically by the thrombin/thrombomodulin complex to…”
    Get full text
    Journal Article
  2. 2

    Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine by Mitani, O, Nishikawa, A, Kurokawa, I, Gabazza, E.C, Ikeda, M, Mizutani, H

    Published in Journal of wound care (01-09-2016)
    “…Objective: To investigate the effect of a novel topical wound-healing agent, low-concentration povidone-iodine ointment (LPIO) with a hydrophobic white…”
    Get full text
    Journal Article
  3. 3

    Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications by Relja, B, Lustenberger, T, Puttkammer, B, Jakob, H, Morser, J, Gabazza, E.C, Takei, Y, Marzi, I

    Published in Immunobiology (1979) (01-04-2013)
    “…Abstract Background Infectious complications frequently occur after major trauma, leading to increased morbidity and mortality. Thrombin-activatable…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) Levels are decreased in Patients With Trauma-Induced Coagulopathy by Lustenberger, T, Relja, B, Puttkammer, B, Gabazza, E.C, Geiger, E, Takei, Y, Morser, J, Marzi, I

    Published in Thrombosis research (01-01-2013)
    “…Abstract Introduction The thrombin-activatable fibrinolysis inhibitor (TAFI) is a potent inhibitor of fibrinolysis. However, the time course of TAFI and its…”
    Get full text
    Journal Article
  6. 6

    A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly by Maruyama, T, Niederman, M.S, Kobayashi, T, Kobayashi, H, Takagi, T, D'Alessandro-Gabazza, C.N, Fujimoto, H, Gil Bernabe, P, Hirohata, S, Nakayama, S, Nishikubo, K, Yuda, H, Yamaguchi, A, Gabazza, E.C, Noguchi, T, Takei, Y, Taguchi, O

    Published in Respiratory medicine (01-09-2008)
    “…Summary There are no prospective comparison of the etiology and clinical outcome between hospital-acquired pneumonia (HAP) and nursing home-acquired pneumonia…”
    Get full text
    Journal Article
  7. 7
  8. 8

    IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis by Morioka, T., Yamanaka, K., Mori, H., Omoto, Y., Tokime, K., Kakeda, M., Kurokawa, I., Gabazza, E.C., Tsubura, A., Yasutomi, Y., Mizutani, H.

    Published in British journal of dermatology (1951) (01-06-2009)
    “…Summary Background  Atopic dermatitis (AD) is a chronic disease with a Th2‐type‐cytokine dominant profile. Several cytokines and related peptides have been…”
    Get full text
    Journal Article
  9. 9

    Circulating fibrocytes correlate with the asthma control test score by Kobayashi, H, Naito, M, Masuya, M, Maruyama, M, Urata, K, Takahashi, Y, Tomaru, A, Fujiwara, K, Ohnishi, M, Takagi, T, Kobayashi, T, D'Alessandro-Gabazza, C, Urawa, M, Gabazza, E C, Taguchi, O, Takei, Y

    Published in Allergologia et immunopathologia (01-05-2016)
    “…Bronchial asthma is characterised by airway inflammation and remodelling with a decline of lung function. Fibrocytes are bone marrow-derived mesenchymal…”
    Get more information
    Journal Article
  10. 10

    Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator by HAYASHI, T., NISHIOKA, J., NAKAGAWA, N., KAMADA, H., GABAZZA, E. C., KOBAYASHI, T., HATTORI, A., SUZUKI, K.

    Published in Journal of thrombosis and haemostasis (01-07-2007)
    “…Summary Background: Hepatocyte growth factor (HGF) plays an important role in tissue repair and regeneration. HGF activator (HGFA), a factor XIIa‐like serine…”
    Get full text
    Journal Article
  11. 11

    High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double‐deficient mice by BEPPU, T., GIL‐BERNABE, P., BOVEDA‐RUIZ, D., D'ALESSANDRO‐GABAZZA, C., MATSUDA, Y., TODA, M., MIYAKE, Y., SHIRAKI, K., MURATA, M., MURATA, T., YANO, Y., MORSER, J., GABAZZA, E. C., TAKEI, Y.

    Published in Journal of thrombosis and haemostasis (01-11-2010)
    “…Background: Activation of the complement system has been implicated in tumor growth. The antifibrinolytic protein, activated thrombin‐activatable fibrinolysis…”
    Get full text
    Journal Article
  12. 12

    Pulmonary hypertension is ameliorated in mice deficient in thrombin‐activatable fibrinolysis inhibitor by QIN, L., D’ALESSANDRO‐GABAZZA, C. N., AOKI, S., GIL‐BERNABE, P., YANO, Y., TAKAGI, T., BOVEDA‐RUIZ, D., RAMIREZ MARMOL, A. Y., SAN MARTIN MONTENEGRO, V. T., TODA, M., MIYAKE, Y., TAGUCHI, O., TAKEI, Y., MORSER, J., GABAZZA, E. C.

    Published in Journal of thrombosis and haemostasis (01-04-2010)
    “…Background: The fibrinolytic system has been implicated in the pathogenesis of pulmonary hypertension (PH). Thrombin‐activatable fibrinolysis inhibitor (TAFI)…”
    Get full text
    Journal Article
  13. 13

    Protective Effect of Thrombomodulin in a Murine Model of Allergen-Induced Asthma by Takagi, T, Onishi, M, Urawa, M, Naito, M, Fujiwara, A, Kobayashi, T, Kobayashi, H, Toda, M, Boveda, D, Gil-Bernabe, P, D'Alessandro-Gabazza, C.N, Morser, J, Taguchi, O, Gabazza, E.C

    Published in Journal of allergy and clinical immunology (01-02-2011)
    “…Thrombomodulin (TM), the thrombin receptor on the endothelial cell surface, plays an important role in coagulation and inflammation by inactivating thrombin…”
    Get full text
    Journal Article
  14. 14

    Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy‐associated tubulointerstitial fibrosis by BRUNO, N. E., YANO, Y., TAKEI, Y., GABAZZA, E. C., QIN, L., NAGASHIMA, M., MORSER, J., D'ALESSANDRO‐GABAZZA, C. N., TAGUCHI, O., SUMIDA, Y.

    Published in Journal of thrombosis and haemostasis (01-01-2008)
    “…Background: Thrombin‐activatable fibrinolysis inhibitor (TAFI) has been reported to affect wound healing and fibrotic processes, but its role in renal…”
    Get full text
    Journal Article
  15. 15

    Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions by Hayashi, T., Nishioka, J., Kamada, H., Asanuma, K., Kondo, H., Gabazza, E. C., Ido, M., Suzuki, K.

    Published in Journal of thrombosis and haemostasis (01-06-2004)
    “…In humans, protein C inhibitor (PCI) is expressed in various tissues and present in many body fluids including plasma and seminal fluid. In rodents, PCI is…”
    Get full text
    Journal Article
  16. 16

    Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension by NISHII, Y., GABAZZA, E.C., FUJIMOTO, H., NAKAHARA, H., TAKAGI, T., BRUNO, N., D'ALESSANDRO‐GABAZZA, C. N., MARUYAMA, J., MARUYAMA, K., HAYASHI, T., ADACHI, Y., SUZUKI, K., TAGUCHI, O.

    Published in Journal of thrombosis and haemostasis (01-11-2006)
    “…Background: Protein C inhibitor (PCI) plays a role in multiple biological processes including fertilization, coagulation, fibrinolysis and kinin systems…”
    Get full text
    Journal Article
  17. 17

    Activation of protein C pathway in the airways by Hataji, O, Taguchi, O, Gabazza, E C, Yuda, H, Fujimoto, H, Suzuki, K, Adachi, Y

    Published in Lung (01-01-2002)
    “…The protein C (PC) pathway plays important roles in the regulation of the coagulation system and inflammatory response. This study evaluated the degree of PC…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Protein S is protective in pulmonary fibrosis by Urawa, M., Kobayashi, T., D'Alessandro‐Gabazza, C. N., Fujimoto, H., Toda, M., Roeen, Z., Hinneh, J. A., Yasuma, T., Takei, Y., Taguchi, O., Gabazza, E. C.

    Published in Journal of thrombosis and haemostasis (01-08-2016)
    “…Essentials Epithelial cell apoptosis is critical in the pathogenesis of idiopathic pulmonary fibrosis. Protein S, a circulating anticoagulant, inhibited…”
    Get full text
    Journal Article
  20. 20

    Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells by Chelakkot‐Govindalayathil, A.‐L., Mifuji‐Moroka, R., D'Alessandro‐Gabazza, C. N., Toda, M., Matsuda, Y., Gil‐Bernabe, P., Roeen, Z., Yasuma, T., Yano, Y., Gabazza, E. C., Iwasa, M., Takei, Y.

    Published in Journal of thrombosis and haemostasis (01-01-2015)
    “…Summary Background Alcohol consumption is a major cause of liver injury but the mechanisms are not completely understood. Protein S (PS) is an anticoagulant…”
    Get full text
    Journal Article